Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Agan

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 29, 2015
Reply to Yang et alAnuradha Ganesan, Octavio Mesner, Brian Agan
Journal of Biopharmaceutical Statistics|January 25, 2015
Inference for Surrogate Endpoint Validation in the Binary CaseIonut Bebu, Thomas Mathew, Brian Agan
MSMR|October 28, 2024
Guest editorial: health policy analysis on improving HIV PrEP implementation to help end the HIV epidemic in the U.S. militaryJames D Mancuso, Jason Blaylock, Scott Robinson, et al.
Military Medicine|November 29, 2019
Biomedical Response to Neisseria gonorrhoeae and Other Sexually Transmitted Infections in the US MilitaryEric Garges, June Early, Sandra Waggoner, et al.
AIDS Research and Human Retroviruses|November 25, 2014
Short Communication: HIV RNA Levels Predict AIDS-Defining and Non-AIDS-Defining Cancers After Antiretroviral Therapy Initiation Among HIV-Infected AdultsNancy F Crum-Cianflone, Xun Wang, Anuradha Ganesan, et al.
AIDS Research and Human Retroviruses|October 25, 2016
Humoral Antibody Responses to HIV Viral Proteins and to CD4 Among HIV Controllers, Rapid and Typical Progressors in an HIV-Positive Patient CohortElizabeth Fink, Katherine Fuller, Brian Agan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2010
Trends and causes of hospitalizations among HIV-infected persons during the late HAART era: what is the impact of CD4 counts and HAART use?Nancy F Crum-Cianflone, Greg Grandits, Sara Echols, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 12, 2005
Azithromcyin might not protect against Treponema pallidum infection or reactivation in HIV type 1-infected patientsKatherine Spooner, R Vincent Barthel, Janelle Robertson, et al.
Annals of Neurology|February 16, 2024
White and Gray Matter Changes are Associated With Neurocognitive Decline in HIV InfectionAlice Chien, Tianxia Wu, Chuen-Yen Lau, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2018
Herpes Zoster Rates Continue to Decline in People Living With Human Immunodeficiency Virus but Remain Higher Than Rates Reported in the General US PopulationLaura Gilbert, Xun Wang, Robert Deiss, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 29, 2015
Reply to Yang et alAnuradha Ganesan, Octavio Mesner, Brian Agan
Journal of Biopharmaceutical Statistics|January 25, 2015
Inference for Surrogate Endpoint Validation in the Binary CaseIonut Bebu, Thomas Mathew, Brian Agan
MSMR|October 28, 2024
Guest editorial: health policy analysis on improving HIV PrEP implementation to help end the HIV epidemic in the U.S. militaryJames D Mancuso, Jason Blaylock, Scott Robinson, et al.
Military Medicine|November 29, 2019
Biomedical Response to Neisseria gonorrhoeae and Other Sexually Transmitted Infections in the US MilitaryEric Garges, June Early, Sandra Waggoner, et al.
AIDS Research and Human Retroviruses|November 25, 2014
Short Communication: HIV RNA Levels Predict AIDS-Defining and Non-AIDS-Defining Cancers After Antiretroviral Therapy Initiation Among HIV-Infected AdultsNancy F Crum-Cianflone, Xun Wang, Anuradha Ganesan, et al.
AIDS Research and Human Retroviruses|October 25, 2016
Humoral Antibody Responses to HIV Viral Proteins and to CD4 Among HIV Controllers, Rapid and Typical Progressors in an HIV-Positive Patient CohortElizabeth Fink, Katherine Fuller, Brian Agan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2010
Trends and causes of hospitalizations among HIV-infected persons during the late HAART era: what is the impact of CD4 counts and HAART use?Nancy F Crum-Cianflone, Greg Grandits, Sara Echols, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 12, 2005
Azithromcyin might not protect against Treponema pallidum infection or reactivation in HIV type 1-infected patientsKatherine Spooner, R Vincent Barthel, Janelle Robertson, et al.
Annals of Neurology|February 16, 2024
White and Gray Matter Changes are Associated With Neurocognitive Decline in HIV InfectionAlice Chien, Tianxia Wu, Chuen-Yen Lau, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2018
Herpes Zoster Rates Continue to Decline in People Living With Human Immunodeficiency Virus but Remain Higher Than Rates Reported in the General US PopulationLaura Gilbert, Xun Wang, Robert Deiss, et al.
Pageof 3